Fredun Pharmaceuticals Director Discloses Shareholding Change via Preferential Allotment
Fredun Pharmaceuticals Limited announced that it received disclosures from Director Fredun Nariman Medhora on March 26, 2026, related to changes in his holding of company securities.According to a filing, Fredun Nariman Medhora, Director, increased his shareholding through a preferential allotment. Prior to the acquisition, Medhora held 179,672 equity shares, representing 3.35% of the company. Following the allotment, his holding increased to 286,340 equity shares, constituting 5.23% of the company. The value of the shares acquired was Rs. 13,33,35,000.The acquisition occurred on March 25, 2026, and the intimation to the company was received on...